• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Krka`s Pomalidomide Receives Approval in Europe

    EMA

    Krka`s febuxostat Receives Approval in Europe

    EMA

    Krka, d.d. Novo mesto`s Febuxostat Krka ( Febuxostat) Receives Approval in Europe

    EMA

    Krka, d.d. Pemetrexed Receives Approval In Europe

    EMA

    KRKA, d.d., Novo mesto`s Efavirenz / Emtricitabine / Tenofovir Disoproxil Receives Approval In Europe

    EMA

    KRKA, d.d., Novo mesto`s darunavir Receives Approval In Europe

    EMA

    EU approves CV benefit claim for Novo’s Victoza

    PHARMA TIMES

    Krka, D.D., Novo Mesto Emtricitabine/Tenofovir Disoproxil Receives Approval In Europe

    EMA

    KRKA, d.d., Novo mesto`s Emtricitabine (Tenofovir disoproxil Krka) Receives Approval In Europe

    EMA

    The Top 100 Manufacturers Of Generic Pharmaceuticals Worldwide

    PR NEWSWIRE

    Eight Medicines win CHMP Nod

    PHARMATIMES

    India`s Alkem Labs accused of fudging trial data by German regulator

    REUTERS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.